Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

209,989 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II clinical trial of neoadjuvant anti-PD-1 (toripalimab) combined with axitinib in resectable mucosal melanoma.
Lian B, Li Z, Wu N, Li M, Chen X, Zheng H, Gao M, Wang D, Sheng X, Tian H, Si L, Chi Z, Wang X, Lai Y, Sun T, Zhang Q, Kong Y, Long GV, Guo J, Cui C. Lian B, et al. Among authors: wang x, wang d. Ann Oncol. 2024 Feb;35(2):211-220. doi: 10.1016/j.annonc.2023.10.793. Epub 2023 Nov 11. Ann Oncol. 2024. PMID: 37956739 Free article. Clinical Trial.
LRG1 promotes atherosclerosis by inducing macrophage M1-like polarization.
Wang J, Wang J, Zhong J, Liu H, Li W, Chen M, Xu L, Zhang W, Zhang Z, Wei Z, Guo J, Wang X, Sui J, Liu X, Zhang S, Wang X. Wang J, et al. Among authors: wang x. Proc Natl Acad Sci U S A. 2024 Aug 27;121(35):e2405845121. doi: 10.1073/pnas.2405845121. Epub 2024 Aug 23. Proc Natl Acad Sci U S A. 2024. PMID: 39178231
209,989 results
You have reached the last available page of results. Please see the User Guide for more information.